My Meeting Experience: A Pathologist’s Perspective, Dr. Farah R. Abdulla

My Meeting Experience: A Pathologist’s Perspective, Dr. Farah R. Abdulla

Dr. Farah R. Abdulla
Farah R. Abdulla, MD, is a dermatologist and dermatopathologist and assistant professor of medicine with the University of Chicago Medicine. In the following interview, she discusses what she learned from her first ASCO Annual Meeting experience and provides advice to attendees.

ASCO Daily News: How do you plan out your time during the ASCO Annual Meeting?

Dr. Abdulla: I plan out my time at the Meeting by using the iPlanner app. I make it a point to attend any sessions in the area of cutaneous lymphoma, pathology of lymphomas, and health services research.

ASCO Daily News: Why is it important for pathologists to attend the ASCO Annual Meeting?

Dr. Abdulla: Oncologists are at the heart of the patient–physician interaction, but there are many care providers who assist with the final recommendations made to a patient. Radiology and pathology are integral to those recommendations. Tissue is needed to make the diagnosis and assess the response to therapy. Today, in this era of personalized medicine, the tissue also can assist in deciding the best therapy to pursue in light of the tumor profile.

ASCO Daily News: What advice do you have for first-time attendees to get the most out of their Meeting experience?

Dr. Abdulla: Dive in! It is a great meeting that brings together people from various medical disciplines—physicians, researchers, support staff, and industry. It is a time to meet with colleagues and focus on the science that can change the tomorrow for many of the patients we see today. Take advantage of the iPlanner app to plan out the sessions you want to attend, and for the sessions you miss, check out Meeting Videos and Slides at to catch up.•

About Dr. Abdulla: Dr. Abdulla provides expert care for patients with cutaneous T-cell and B-cell lymphomas. Her research focuses on developing new protocols and treatments for patients with cutaneous lymphomas, including mycosis fungoides.